Prediction Case File
YouTubeEvaluation Complete

Chris Markoch shares 3 high free cash flow stocks for investors who want to sleep better!!

3 extracted signals · 3 resolved · 0 still active

MarketBeat profile imageMarketBeat17 Nov 2025, 04:34 UTC
Video preview for Chris Markoch shares 3 high free cash flow stocks for investors who want to sleep better!!
Signals
3
Eligible signals in this source
Open
0
Still being tracked
Resolved
3
Evaluable outcomes
Successful
2
Canonical correct result
Failed
1
Canonical failed result
Resolved success
66.67%
Open and excluded signals omitted
Source overview

AI-generated source summary

The fundamental analysis focuses on free cash flow yield as a key metric, identifying stocks growing their balance sheet and provides investor security. The analyst identifies three specific stocks: Salesforce, Applied Materials, and Gilead Sciences, and mentions the price predictions for each one. Salesforce, with ticker CRM, has a 5.06% free cash flow yield, most of its ten billion revenue coming from recurring revenue and has a price forecast of $325.23. Applied Materials, with ticker AMAT, has a 3.07% free cash flow yield and is positioned to benefit from growth in AI and data centers with 1.4 billion in buybacks with a high estimate up to 300 and an average target price for 2025 of $226.09. The third stock, Gilead Sciences, with ticker GILD, and a 6.19% free cash flow, and a forecast average target price of $129.13, and has existing proven drug portfolio used to treat HIV and Hepatitis C. No risk analysis is provided.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    3 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

MarketBeat

Tracked signals
987
Historical success
42.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.